Endo Pharmaceuticals/American Medical Systems
On April 11, 2011, Endo Pharmaceuticals (Nasdaq: ENDP) and American Medical Systems (AMS) (Nasdaq: AMMD) have entered into a definitive agreement whereby Endo will acquire American Medical for $30 per share, or $2.9 billion in cash, which includes the assumption and repayment of $312 million of American Medical debt.
Under the terms of the merger agreement, which has been unanimously approved by the Boards of Directors of both companies, Endo will acquire 100 percent of the shares of American Medical for $30 per share. Endo has fully committed financing in place to complete the transaction.
Closing is expected in Q311.
Morgan Stanley and BofA Merrill Lynch have provided fully committed financing to Endo to close this transaction.
Under the terms of the merger agreement, which has been unanimously approved by the Boards of Directors of both companies, Endo will acquire 100 percent of the shares of American Medical for $30 per share. Endo has fully committed financing in place to complete the transaction.
Closing is expected in Q311.
Morgan Stanley and BofA Merrill Lynch have provided fully committed financing to Endo to close this transaction.
